comparemela.com

Latest Breaking News On - Campbell newman asset management inc - Page 4 : comparemela.com

Campbell Newman Asset Management Inc Decreases Holdings in Exxon Mobil Co (NYSE:XOM)

Campbell Newman Asset Management Inc. cut its holdings in shares of Exxon Mobil Co. (NYSE:XOM – Free Report) by 8.5% during the 4th quarter, HoldingsChannel reports. The fund owned 5,383 shares of the oil and gas company’s stock after selling 500 shares during the quarter. Campbell Newman Asset Management Inc.’s holdings in Exxon Mobil were […]

Medpace Holdings, Inc (NASDAQ:MEDP) Shares Acquired by Wakefield Asset Management LLLP

Wakefield Asset Management LLLP increased its position in shares of Medpace Holdings, Inc. (NASDAQ:MEDP – Free Report) by 10.8% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 3,607 shares of the company’s stock after buying an additional 351 shares during the quarter. Wakefield […]

Medpace Holdings, Inc (NASDAQ:MEDP) Shares Acquired by Wakefield Asset Management LLLP

Wakefield Asset Management LLLP increased its position in shares of Medpace Holdings, Inc. (NASDAQ:MEDP – Free Report) by 10.8% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 3,607 shares of the company’s stock after buying an additional 351 shares during the quarter. Wakefield […]

Monolithic Power Systems, Inc (NASDAQ:MPWR) Shares Sold by Campbell Newman Asset Management Inc

Campbell Newman Asset Management Inc. decreased its position in shares of Monolithic Power Systems, Inc. (NASDAQ:MPWR – Free Report) by 12.7% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 5,248 shares of the semiconductor company’s stock after selling 763 shares during the […]

Campbell Newman Asset Management Inc Trims Holdings in Bristol-Myers Squibb (NYSE:BMY)

Campbell Newman Asset Management Inc. trimmed its position in Bristol-Myers Squibb (NYSE:BMY – Free Report) by 45.3% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 17,957 shares of the biopharmaceutical company’s stock after selling 14,869 shares during the period. […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.